Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
To support the development of a patient-reported outcome measure to improve the timeliness and quality of cancer diagnosis.
Thank you for sharing.
RAND Corporation
$453,443
24 months
A Framework for Assessing the Costs of Delayed Diagnosis
Jul 2023
$498,143
18 months
A Patient-Reported Outcome Performance Measure to Improve the Timeliness and Quality of Cancer Diagnosis
Jul 2022
$2,221,658
36 months
Developing Measures of the Care Experienced by High-Need Patients
Nov 2017
Creating positive outcomes for future generations.